TC
OGN icon

Truvestments Capital’s Organon & Co OGN Stock Holding History

Truvestments Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-51
Closed -$545 – 1085
2025
Q3 		$545 Hold
51
– – ﹤0.01% 970
2025
Q2 		$494 Hold
51
– – ﹤0.01% 898
2025
Q1 		$759 Sell
51
-5
-9% -$77 ﹤0.01% 942
2024
Q4 		$836 Buy
56
+5
+10% +$81 ﹤0.01% 932
2024
Q3 		$976 Buy
+51
New +$1.06K ﹤0.01% 855
2024
Q2 		– Sell
-52
Closed -$978 – 530
2024
Q1 		$978 Sell
52
-532
-91% -$9.13K ﹤0.01% 649
2023
Q4 		$8.42K Buy
584
+38
+7% +$517 ﹤0.01% 531
2023
Q3 		$9.48K Sell
546
-42
-7% -$876 ﹤0.01% 459
2023
Q2 		$12.2K Buy
588
+6
+1% +$130 0.01% 435
2023
Q1 		$13.7K Buy
582
+5
+0.9% +$134 0.01% 409
2022
Q4 		$16.1K Sell
577
-385
-40% -$9.84K 0.01% 410
2022
Q3 		$23K Sell
962
-14
-1% -$423 0.01% 326
2022
Q2 		$33K Buy
+976
New +$34.2K 0.02% 300
2022
Q1 		– Sell
-1,406
Closed -$43K – 421
2021
Q4 		$43K Buy
+1,406
New +$45.8K 0.02% 283

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Truvestments Capital's OGN Position: Q4 2025 in Review

Truvestments Capital sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 51 shares — an estimated $545 sold.

Truvestments Capital first reported a position in OGN in Q4 2021 and held it in 14 quarters. The position peaked at $43K in Q4 2021. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Truvestments Capital reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Truvestments Capital sold 51 Organon & Co shares in Q4 2025, an estimated $545.
  • Truvestments Capital first reported a position in Organon & Co in Q4 2021 and held it in 14 quarters.
  • Truvestments Capital's Organon & Co position peaked at $43K in Q4 2021.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Truvestments Capital's 13F filing for Q4 2025, filed 13 Feb 2026.